Literature DB >> 2739919

Linkage analysis in familial amyotrophic lateral sclerosis.

T Siddique1, M A Pericak-Vance, B R Brooks, R P Roos, W Y Hung, J P Antel, T L Munsat, K Phillips, K Warner, M Speer.   

Abstract

Familial amyotrophic lateral sclerosis (FALS) constitutes 5 to 10% of cases of ALS and, in most families, its inheritance is consistent with an autosomal dominant trait with age-dependent penetrance. The biochemical abnormality underlying the disorder is unknown. We analyzed DNA from 131 members of 6 multigenerational ALS families, which included 13 affected members, for genetic linkage to 39 expressed and DNA markers, using the techniques of 2-point linkage analysis, multilocus linkage analysis, and exclusion mapping. We identified FALS families with structures suitable for linkage, by computer simulation techniques. A DNA bank established to provide optimum use of available FALS families provided DNA from immortalized lymphoblast cell lines and frozen postmortem tissue. We could not link FALS to any of the markers studied, but excluded chromosome regions unlikely to be a locus of the FALS gene. With the help of this exclusion data, we will concentrate on regions of the human genome that remain unexcluded.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2739919     DOI: 10.1212/wnl.39.7.919

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Pathological characterization of astrocytic hyaline inclusions in familial amyotrophic lateral sclerosis.

Authors:  S Kato; H Hayashi; K Nakashima; E Nanba; M Kato; A Hirano; I Nakano; K Asayama; E Ohama
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Familial adult amyotrophic lateral sclerosis: report of cases.

Authors:  M Maurelli; E Marchioni; D Bosone; S Boni; W Bolzani; R Cerretano; F Simonetti; F Savoldi
Journal:  Ital J Neurol Sci       Date:  1992-02

Review 3.  Making connections: pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia.

Authors:  Faisal Fecto; Teepu Siddique
Journal:  J Mol Neurosci       Date:  2011-09-07       Impact factor: 3.444

4.  Potential therapeutic drugs and methods for the treatment of amyotrophic lateral sclerosis.

Authors:  G Yacila; Y Sari
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

5.  The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease.

Authors:  Z Mourelatos; N K Gonatas; A Stieber; M E Gurney; M C Dal Canto
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

6.  Lower motor neuron degeneration and familial predisposition to colonic neoplasia in two adult siblings.

Authors:  P J Shaw; P G Ince; J Slade; J Burn; N E Cartlidge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

7.  Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22.

Authors:  K C Wilhelmsen; T Lynch; E Pavlou; M Higgins; T G Nygaard
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

8.  Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity.

Authors:  D R Borchelt; M K Lee; H S Slunt; M Guarnieri; Z S Xu; P C Wong; R H Brown; D L Price; S S Sisodia; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

9.  Familial amyotrophic lateral sclerosis with a mutation in the Cu/Zn superoxide dismutase gene.

Authors:  H Takahashi; T Makifuchi; R Nakano; S Sato; T Inuzuka; K Sakimura; M Mishina; Y Honma; S Tsuji; F Ikuta
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 10.  Searching Far and Genome-Wide: The Relevance of Association Studies in Amyotrophic Lateral Sclerosis.

Authors:  Kelly A Rich; Jennifer Roggenbuck; Stephen J Kolb
Journal:  Front Neurosci       Date:  2021-01-14       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.